Jiri Homolka
Overview
Explore the profile of Jiri Homolka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
251
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Freitag-Wolf S, Schupp J, Frye B, Fischer A, Anwar R, Kieszko R, et al.
Front Med (Lausanne)
. 2023 Aug;
10:1218106.
PMID: 37621457
Introduction: Sarcoidosis is a highly variable disease in terms of organ involvement, type of onset and course. Associations of genetic polymorphisms with sarcoidosis phenotypes have been observed and suggest genetic...
2.
Zurkova M, Kriegova E, Kolek V, Lostakova V, Sterclova M, Bartos V, et al.
Respir Res
. 2019 Jan;
20(1):16.
PMID: 30665416
Introduction: Pirfenidone, an antifibrotic drug, slows-down the disease progression in idiopathic pulmonary fibrosis (IPF) over 12 months, however limited data on the decline of lung function and overall survival (OS)...
3.
Schupp J, Freitag-Wolf S, Bargagli E, Mihailovic-Vucinic V, Rottoli P, Grubanovic A, et al.
Eur Respir J
. 2018 Jan;
51(1).
PMID: 29371378
Sarcoidosis is a highly variable, systemic granulomatous disease of hitherto unknown aetiology. The GenPhenReSa (Genotype-Phenotype Relationship in Sarcoidosis) project represents a European multicentre study to investigate the influence of genotype...
4.
Doubkova M, Svancara J, Svoboda M, Sterclova M, Bartos V, Plackova M, et al.
Clin Respir J
. 2017 Sep;
12(4):1526-1535.
PMID: 28862397
Introduction: Prognostic factors of idiopathic pulmonary fibrosis (IPF) currently recognized include changes in vital capacity and radiologic findings. However, most of the prognostic studies in IPF are based on clinical...
5.
Pelclova D, Vlckova S, Bezdicek O, Vaneckova M, Urban P, Ridzon P, et al.
Basic Clin Pharmacol Toxicol
. 2016 Dec;
120(6):628-633.
PMID: 27911474
The efficacy of treatment for intravenous elemental mercury intoxication has not been fully studied with regard to clinical outcome, and treatment recommendations vary. We treated a 41-year-old man with a...
6.
Fischer A, Ellinghaus D, Nutsua M, Hofmann S, Montgomery C, Iannuzzi M, et al.
Am J Respir Crit Care Med
. 2015 Jun;
192(6):727-36.
PMID: 26051272
Rationale: Genetic variation plays a significant role in the etiology of sarcoidosis. However, only a small fraction of its heritability has been explained so far. Objectives: To define further genetic...
7.
Buchler T, Homolka J, Fencl P, Rosova B, Hytych V, Abrahamova J
Tumori
. 2013 Dec;
99(4):e159-63.
PMID: 24326853
We describe the case of a patient with metastatic renal cell carcinoma (mRCC) who developed a nontuberculous mycobacteria (NTM)-related pulmonary nodule during therapy with the mammalian target of rapamycin (mTOR)...
8.
Homolka J, Krejbich F, Holub J
Cas Lek Cesk
. 2011 Jul;
150(6):330-3.
PMID: 21751506
Background: The number of notified tuberculosis cases in the Czech Republic in 2009 was lower than in 2008. 710 new tuberculosis cases and relapses were reported. Material And Methods: 598...
9.
Homolka J, Sterclova M, Blaha K
Cas Lek Cesk
. 2010 Jul;
149(6):297-9.
PMID: 20662479
Authors describe two cases of disseminated Mycobacterium bovis infection in two immunocompromised patients with central venous portcatheter. Diagnosis has been confirmed by cultivation from catether material. Antituberculotic treatment lead in...
10.
Homolka J
Cas Lek Cesk
. 2010 May;
149(3):133-4.
PMID: 20429350
Overview of the importance of lung diseases for the world population. International declaration of different respiratory societies which may lead to better prevention, diagnosis and treatment of serious lung diseases.